Good Character<br />By Rev Shark<br />RealMoney.com Contributor<br />8/12/2009 8:55 AM EDT <br /><br />Good character is more to be praised than outstanding talent. Most talents are, to some extent, a gift. Good character, by contrast, is not given to us. We have to build it, piece by piece -- by thought, choice, courage, and determination. <br />-- H. Jackson Brown<br /><br />I like to view the market in terms of character. Good character can take a while to develop, but once it is developed isn't quickly or immediately lost. A market with good character can be expected to have a few stumbles here and there, but it will overcome obstacles and will regroup and continue to act in a positive and promising matter. A market with good character deserves the benefit of the doubt. <br /><br />If you stick with and trust a market with good character, it will treat you well, but the most dangerous time for a market player is when character starts to deteriorate. When bad habits start to develop, when the action become lazy and sloppy and when we become distrustful, it is important to take action. <br /><br />While we always want to give some benefit of the doubt to a market that has been exhibiting good and strong character, we have to be prepared to draw a line at some point. No matter how well the market has acted, a point will come when behavior starts to shift and we need to be more careful. <br /><br />Character is king in the market, and when it changes, we need to adjust. <br /><br />So far this market continues to show superior positive character. We have slipped a little bit the last few days, but it hasn't been anything that we can't forgive, especially in view of how good the action has been for many weeks. Even the best markets are entitled to a few slips. In fact, they are better for them -- especially if they can recover with some gusto. <br /><br />A lot of folks are watching for this market to start falling apart with some vigor, but we still have too much positive character at work. We have to watch for it to be chipped away, but this is a market that has done little wrong so far, and it is going to stand up much better than some folks think. That doesn't mean we shouldn't be ready to be more cautious, and we certainly need to make sure we are taking gains and keeping stops fairly tight, but this market still hasn't not done much wrong, and that is the sort of character that deserves respect. <br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: EJ +18.0%, JAZZ +16.6%, CAAS +13.9% (light volume), WX +13.4%, ADCT +11.6%, MFB +11.6% (light volume), CREE +8.5% (also upgraded to Neutral at BofA/Merrill), TOL +7.2%, TGB +5.8%, PRGN +4.1%, AMAT +2.1%, CCJ +1.6%... Select homebuilders ticking higher following TOL results: HOV +7.9%, SPF +4.6%, DHI +4.2%, BZH +4.1%, XHB +3.2%, LEN +2.7%... Select oil/gas related names showing strength: TOT +1.9%, RDS.A +1.5%, STO +1.2%, E +1.0%... Other news: DVAX +8.6% (plans for continued clinical development of HEPLISAVTM Phase 3 investigational adult hepatitis B vaccine in Europe), ADY +8.0% (still checking), RBS +4.6% (still checking for anything specific), CLNE +4.3% (Cramer makes positive comments on MadMoney), SGEN +2.5% (announces pricing of public offering of common stock at $10.75; also initiated with Buy and $14 tgt at Deutsche), ASML +2.2% (still checking), FMC +1.6% (will replace Centex in the S&P 500)... Analyst comments: CVGI +11.1% (upgraded to Overweight at JPMorgan), BPI +3.9% (upgraded to Overweight from Neutral at Piper Jaffray), LINTA +3.6% (upgraded to Buy at BofA/Merrill), ALL +2.5% (upgraded to Buy at BofA/Merrill), BUCY +2.0% (added to Conviction Buy list at Goldman- Reuters), VRSN +2.0% (upgraded to Outperform at Credit Suisse), IP +1.7% (added to Conviction Buy list at Goldman- Reuters).<br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: GU -14.3%, CLWR -10.9%, LIZ -9.0%, BOBE -7.9%, VISN -7.5%, JASO -6.7%, SYMM -5.1%, SLE -2.8% (light volume), ING -2.0%, M -1.7%, SQM -1.5%... Select ag/chem related names ticking lower: MOS -1.7%, POT -1.6%, DOW -1.2%, DD -1.2% (trading ex dividend)... Other news: VNR -12.9% (announces public offering of 3.5 mln common units), IMAX -6.1% (prices public offering of 5,882,353 of its common shares at $8.50 per share), PETD -6.1% (priced its 3.75 mln share common stock offering at $12/share), AWK -6.0% (announces a 30 mln share common stock offering; all of the shares will be sold by the selling stockholder), BPO -5.5% (to raise $900 mln in common share offering), AINV -5.0% (announces public offering of 2.25 mln shares), MPEL -4.9% (announces commencement of follow on 37.5 mln ADR public offering), SSRI -3.9% (announces $46 mln public offering of common shares), RNWK -3.8% (RealNetworks loses ruling on DVD copying - WSJ), RTP -3.2% (Rio Tinto workers face formal charges in China - WSJ)... Analyst comments: YRCW -8.7% (downgraded to Sell from Hold at Stifel Nicolaus), GRMN -4.8% (added to Americas Conviction Sell List at Goldman- Reuters), TXRH -4.5% (downgraded to Neutral from Outperform at Cowen), LPX -3.3% (ticking lower; hearing weakness attributed to downgrade at tier 1 firm), SPWRA -2.9% (downgraded to Underperform at BofA/Merrill).